Jovian Yu

947 total citations
25 papers, 506 citations indexed

About

Jovian Yu is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Jovian Yu has authored 25 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Immunology and 5 papers in Genetics. Recurrent topics in Jovian Yu's work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). Jovian Yu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). Jovian Yu collaborates with scholars based in United States, United Kingdom and Canada. Jovian Yu's co-authors include Thomas F. Gajewski, Robin Reschke, Ken Hatogai, Emily F. Higgs, Blake Flood, James Godfrey, Justin Kline, Sherin J. Rouhani, Robbert M. Spaapen and Douglas E. Kline and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunity.

In The Last Decade

Jovian Yu

22 papers receiving 501 citations

Peers

Jovian Yu

ONCOL

IMMUN

PRM

Christian Seitz Germany

Ashley Plant United States

Iñigo Terrén Spain

Sabrina Carpentier France

Liliana E. Lucca United States

Athalia R. Pyzer United States

Remy Thomas Qatar

Jayakumar Vadakekolathu United Kingdom

Thomas Magg Germany

Jonathan Chabon United States

Christian Seitz Germany

Jovian Yu

338 ×1.5

ONCOL

205 ×0.9

IMMUN

246 ×1.4

55 ×0.9

PRM

43 ×0.7

Citations per year, relative to Jovian Yu Jovian Yu (= 1×) peers Christian Seitz

Countries citing papers authored by Jovian Yu

Since Specialization

Citations

This map shows the geographic impact of Jovian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jovian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jovian Yu more than expected).

Fields of papers citing papers by Jovian Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jovian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jovian Yu. The network helps show where Jovian Yu may publish in the future.

Co-authorship network of co-authors of Jovian Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jovian Yu. A scholar is included among the top collaborators of Jovian Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jovian Yu. Jovian Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Xiufen, Jovian Yu, Girish Venkataraman, et al.. (2024). T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses. Cancer Immunology Research. 12(3). 296–307. 1 indexed citations

Cooper, Alan, Girish Venkataraman, Joo Y. Song, et al.. (2023). CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition. Journal of Clinical Oncology. 42(4). 467–480. 10 indexed citations

Godfrey, James, Xiufen Chen, Nicole Sunseri, et al.. (2023). TIGIT is a key inhibitory checkpoint receptor in lymphoma. Journal for ImmunoTherapy of Cancer. 11(6). e006582–e006582. 13 indexed citations

Cooper, Alan, Girish Venkataraman, Joo Y. Song, et al.. (2023). A CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition. Blood. 142(Supplement 1). 851–851. 2 indexed citations

Rouhani, Sherin J., Jovian Yu, Daniel J. Olson, et al.. (2022). Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies. Journal for ImmunoTherapy of Cancer. 10(6). e004766–e004766. 8 indexed citations

Reschke, Robin, Jason W. Shapiro, Jovian Yu, et al.. (2022). Checkpoint Blockade–Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines. Cancer Immunology Research. 10(10). 1167–1174. 62 indexed citations

Briquez, Priscilla S., Sherin J. Rouhani, Jovian Yu, et al.. (2022). Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Science Advances. 8(40). eabn3777–eabn3777. 31 indexed citations

MacNabb, Brendan W., Xiufen Chen, James Godfrey, et al.. (2022). Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing. Immunity. 55(6). 982–997.e8. 105 indexed citations

Henick, Brian S., Franz Villarroel‐Espíndola, Ila Datar, et al.. (2022). Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 10(7). e005025–e005025. 7 indexed citations

10.

Gurbuxani, Sandeep, Jeffrey Mueller, Aliya N. Husain, et al.. (2022). Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents. Blood Advances. 6(24). 6249–6262. 13 indexed citations

11.

Godfrey, James, Hongtao Liu, Jovian Yu, et al.. (2022). Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Advances. 7(6). 963–970. 15 indexed citations

12.

Yu, Jovian, Brian C.‐H. Chiu, Timothy Carll, et al.. (2021). Loss of 5-hydroxymethylcytosine expression is near-universal in B-cell lymphomas with variable mutations in epigenetic regulators. Haematologica. 107(4). 966–969. 3 indexed citations

13.

Reschke, Robin, Jovian Yu, Blake Flood, et al.. (2021). Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma. Journal for ImmunoTherapy of Cancer. 9(9). e003521–e003521. 98 indexed citations

14.

Yu, Jovian, Cynthia Tsay, Clarence T. Sasaki, et al.. (2021). Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs. Oral Oncology. 122. 105585–105585. 3 indexed citations

15.

Yu, Jovian, et al.. (2017). A Needs Assessment of Social Support Among Medical Physicists: Stress, Medical Error, and Burnout. International Journal of Radiation Oncology*Biology*Physics. 99(2). S72–S73. 1 indexed citations

16.

Lester-Coll, N.H., Jovian Yu, Joseph N. Contessa, et al.. (2016). Mibefradil Dihydrochloride With Hypofractionated Radiation for Recurrent Glioblastoma: Preliminary Results of a Phase 1 Dose Expansion Trial. International Journal of Radiation Oncology*Biology*Physics. 96(2). S93–S93. 2 indexed citations

17.

Fei, Dennis Liang, Rakesh Chatrikhi, Jovian Yu, et al.. (2016). Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival. PLoS Genetics. 12(10). e1006384–e1006384. 66 indexed citations

18.

Magnuson, William J., Arya Amini, Tejas Patil, et al.. (2016). Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional Analysis. International Journal of Radiation Oncology*Biology*Physics. 96(2). S57–S58. 1 indexed citations

19.

Brodsky, Alexander S., Andrew Fischer, Daniel Miller, et al.. (2014). Expression Profiling of Primary and Metastatic Ovarian Tumors Reveals Differences Indicative of Aggressive Disease. PLoS ONE. 9(4). e94476–e94476. 52 indexed citations

20.

Yakirevich, Evgeny, Ayman Samkari, Michael P. Holloway, et al.. (2011). Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer. Human Pathology. 43(6). 865–873. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact